Skip to main content

Table 2 Demographic and clinical characteristics of the study population

From: Telephone-based assessment of multiple sclerosis patients at Ain Shams University Hospital in the coronavirus disease 2019 pandemic

  Number (percentage)
Age (years) Range 18–58
Median 34
Gender Male 29 (27.6%)
Female 76 (72.4%)
Type of MS RRMS 95 (90.5%)
SPMS 9 (8.5%)
PPMS 1 (1.0%)
Total duration of illness (months) Range 1–25
Median 5
EDSS score Range 0–7
Median 2.5
EDSS grading Mild disability (0–3) 69 (65.7%)
Moderate disability (3.5–6) 28 (26.7%)
Severe disability (˃6) 8 (7.6%)
Number of relapses during the last year No relapse 40 (38.1%)
One relapse 49 (46.7%)
Two relapses 13 (12.4%)
More than two relapses 3 (2.8%)
DMT Interferon beta 49 (46.7%)
Dimethyl fumarate 1 (1.0%)
Teriflunomide 5 (4.7%)
Fingolimod 39 (37.1%)
Rituximab 10 (9.5%)
Ocrelizumab 1 (1.0%)
Hauser Ambulation index Range 0–9
Median 1